speaker-photo

Vernon Hartdegen

Vice President of R&D for Trauma, CMF, Sports, and Extremities at DePuy Synthes

Vernon Hartdegen is a life-long orthopedic professional. After completing his bachelor’s degree in Biomedical Engineering from Louisiana Tech, he joined Smith and Nephew Orthopedics as a product development engineer while simultaneously completing his master’s degree in Biomechanical Engineering from the University of Tennessee. In 2000, he moved to Wright Medical Technology where he progressed through the ranks from engineer to senior director of product development. During his nine-year tenure at Wright, he oversaw the development of the total knee arthroplasty, upper extremity, and foot & ankle product portfolios. Hartdegen then moved into the start-up company environment with senior leadership roles at two companies before co-founding CrossRoads Extremity Systems in 2014. As president and CEO of CrossRoads Extremity Systems, Hartdegen successfully navigated the 2022 acquisition of CrossRoads by DePuy Synthes. He has continued with DePuy Synthes and is currently the vice president of R&D for the DePuy Synthes Trauma, Extremities, CMF, Animal and Sports franchise.

8:45-9:00 a.m.

Wednesday April 24, 2024

Welcome to Memphis

An introduction of the region serving as the host of the 2024 ODT Forum—Memphis, Tenn.—and an overview of why the area is so important to the orthopedic device manufacturing industry.

11:25 a.m.-12:15 p.m.

Wednesday April 24, 2024

OEM/CMO Relationship Outlook: The Impact of Consolidation

With the trend of M&A so prevalent throughout the orthopedic device manufacturing landscape, it is only natural to expect changes to the relationship between OEM and supply partner when an acquisition occurs. What is this impact and how does it affect the overall manufacturing industry? This session will bring together representatives from both OEMs and suppliers who have engaged in M&A to hear from them how existing and new relationships were affected along with related topics intertwined into this discussion.

Moderated by Bryan Hughes